Adaptive Biotechnologies Corporation / Fundamentals
Income statement
- Net revenue
€176.80M - Cost of goods sold
€60.04M - Gross profit
€116.76M - SG&A expenses
€137.20M - R&D expenses
€82.44M - EBITDA
-€84.98M - D&A
€14.38M - EBIT
-€104.34M - Interest expenses
€7.62M - EBT
-€104.45M - Tax expenses
€0.00 - Net income
-€104.44M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€34.35M - Changes in working capital
€9.07M - Operating cash flow
-€69.33M - Capex
€2.01M - Other investing cash flow
€0.00 - Net investing cash flow
€48.53M - Total cash dividends paid
€0.00 - Issuance of common stock
-€63.75K - Debt repayment
€0.00 - Other financing cash flow
€6.23M - Net financing cash flow
€6.23M - Foreign exchange effects
€0.00 - Net change in cash
-€12.01M - Cash at end of period
€39.53M - Free cash flow
-€67.31M
Balance sheet
- Cash and cash equivalents
€37.19M - Cash and short-term investments
€170.48M - Total receivables
€38.15M - Inventory
€7.24M - Other current assets
€9.73M - Total current assets
€225.60M - Property, plant & equipment
€72.71M - Goodwill
€102.50M - Intangible assets
€2.23M - Long-term investments
€20.76M - Other non-current assets
€4.08M - Total non-current assets
€202.28M - Total assets
€427.88M - Accounts payable
€5.95M - Short-term debt
€8.58M - Other current liabilities
€17.21M - Total current liabilities
€79.38M - Long-term debt
€64.11M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€112.45M - Total non-current liabilities
€193.81M - Total liabilities
€273.20M - Common stock
€12.92K - Retained earnings
-€1.17B - Other equity
€62.89K - Total equity
€154.68M - Total liabilities and shareholders' equity
€427.88M
Company information
- Market capitalization
€1.53B - Employees
619 - Enterprise Value
€1.65B
Company ratios
- Gross margin
-
66.0% Much better than peer group: -42,551.9% - EBITDA margin
-
-48.1% Much better than peer group: -57,584.9% - EBIT margin
-
-59.0% Much better than peer group: -57,390.9% - EBT margin
-
-59.1% Much better than peer group: -62,232.2% - Net margin
-
-59.1% Much better than peer group: -62,210.4% - ROE
-
-67.5% Worse than peer group: -56.8% - ROA
-
-24.4% Much better than peer group: -130.8% - Asset turnover
-
41.3% Much better than peer group: 15.9% - FCF margin
-
-40.4% Much better than peer group: -49,297.3% - FCF yield
-4.7% - Efficiency ratio
148.1% - Net sales per employee
-
€285.63K - Net income per employee
-
-€168.73K